Predict your next investment

Angel Investor (Individual)
shervin.com

See what CB Insights has to offer

Investments

39

Portfolio Exits

15

About Shervin Pishevar

Shervin Pishevar is an angel investor who generally invests $10k-$250k in young, emerging companies with a focus on very early stage investing. Pishevar aims to assist portfolio companies through efforts and expertise focused on product-market fit, recruiting, positioning and marketing, and business model innovation. Shervin Pishevar an angel investor is the Chief Executive Officer and Founder of SGN, a social and mobile gaming company. Pishevar formerly founded Ionside Interactive. He also is an Advisor at LaunchBox Digital. Shervin was a member of the Technology, Media and Telecommunications (TMT) policy working group that helped create the Obama Technology and Innovation Plan.

Shervin Pishevar Headquarter Location

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Shervin Pishevar News

Nue Life Health Raises $3.3M in Funding

Jun 7, 2021

Backers included Jack Abraham, Shervin Pishevar, Martin Varsavsky, Jon Oringer, James Bailey and Christina Getty. Led by Juan Pablo Cappello, CEO, and Demian Bellumio, CTO, Nue Life Health is developing therapies that provide solutions for brain health, cognitive longevity and treatment of depression, anxiety, bipolar and post traumatic stress disorder. The company intends to use the funds to expand operations, development efforts and its business reach. Currently operating in California, Texas and Florida, Nue plans to rapidly expand across the United States. FinSMEs 07/06/2021

Shervin Pishevar Investments

39 Investments

Shervin Pishevar has made 39 investments. Their latest investment was in NUE Life Health as part of their Angel on June 6, 2021.

CBI Logo

Shervin Pishevar Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

6/3/2021

Angel

NUE Life Health

$3.3M

Yes

Christina Getty, Jack Abraham, James Bailey, Jon Oringer, and Martin Varsavsky

2

2/9/2020

Seed VC

Habitas

$20M

Yes

10100, Div Turakhia, Jonathan Teo, Justin Mateen, Maurice Salem, Mike Novogratz, and Tim Steiner

7

8/15/2019

Seed VC - II

Coinmine

$2.5M

Yes

Canaan Partners, gumi Cryptos, M13, and Republic

10

4/27/2016

Seed VC - II

Subscribe to see more

$99M

Subscribe to see more

10

11/17/2015

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/3/2021

2/9/2020

8/15/2019

4/27/2016

11/17/2015

Round

Angel

Seed VC

Seed VC - II

Seed VC - II

Seed VC

Company

NUE Life Health

Habitas

Coinmine

Subscribe to see more

Subscribe to see more

Amount

$3.3M

$20M

$2.5M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Christina Getty, Jack Abraham, James Bailey, Jon Oringer, and Martin Varsavsky

10100, Div Turakhia, Jonathan Teo, Justin Mateen, Maurice Salem, Mike Novogratz, and Tim Steiner

Canaan Partners, gumi Cryptos, M13, and Republic

Sources

2

7

10

10

10

Shervin Pishevar Portfolio Exits

15 Portfolio Exits

Shervin Pishevar has 15 portfolio exits. Their latest portfolio exit was Poshmark on January 14, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

1/14/2021

IPO

$991

4

7/6/2020

Acquired

$991

114

9/28/2017

Acquired

4

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

Date

1/14/2021

7/6/2020

9/28/2017

00/00/0000

00/00/0000

Exit

IPO

Acquired

Acquired

Subscribe to see more

Subscribe to see more

Companies

Subscribe to see more

Subscribe to see more

Valuation

$991

$991

$991

Acquirer

Subscribe to see more

Subscribe to see more

Sources

4

114

4

10

10

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.